Skip to main content

Table 3 Polysomnography results

From: Sleep problems among children with Fetal Alcohol Spectrum Disorders (FASD)- an explorative study

 

FASD patients (n = 19)

Control group (n = 5)

PSG laboratory control group (n = 105)

p

Age, years

7.1 (5.5; 9.3)

7.5 (6.7; 8.7)

6.5 (4.9; 8.9)

0.7

Male sex, n (%)

8 (42)

3 (60)

66 (63)

0.2

Aquisition time, min

594 (578; 607)

582 (570; 584)

591 (572; 603)

0.4

TIB, min

548 (530; 569)

538 (529; 544)

543 (524; 563)

0.8

TST, min

464 (434; 507)

449 (446; 480)

466 (433; 494)

0.9

SPT, min

526 (502; 543)

512 (509; 534)

517 (494; 537)

0.8

Sleep efficiency, %TIB

86.4 (78.4; 91.1)

82.6 (81.4; 82.9)

86.1 (79.7; 92.8)

0.8

Sleep latency, min

22.5 (7.4; 28,6)

18.9 (11.0; 30.2)

16.0 (5.5; 26.1)

0.5

Stage shifts, n

86 (64; 97)

75 (57; 98)

67 (54; 83)

0.03 a

W, %SPT

9.7 (3.4; 14.7)

12.3 (11.9; 16.5)

9.8 (4.2; 15.2)

0.6

N1, %TST

4.3 (2.6; 5.7)

3.2 (3.0; 3.7)

2.4 (1.8; 3.6)

0.005 a

N2, %TST

53.7 (47.6; 58.0)

54.4 (47.4; 57.3)

50.4 (46.2; 53.5)

0.1

N3, %TST

27.5 (22.1; 31.5)

26.8 (24.6; 29.8)

29.0 (25.0; 32.5)

0.2

REM, %TST

15.1 (14.5; 19.4)

17.8 (17.4; 19.9)

17.6 (14.9; 20.6)

0.4

N3 + REM, %TST

42.5 (39.5; 46.5)

42.5 (37.0; 50.5)

46.7 (42.1; 50.5)

0.03 a

Arousal index, events/h

6.9 (5.9; 8.5)

8.5 (7.7; 9.6)

5.1 (4.1; 6.2)

< 0.0001 a,b

Total apnea index, events/h

1.0 (0.7; 1.8)

2.1 (0.8; 5.4)

 

0.3

Central apnea index, events/h

1.0 (0.5; 1.8)

2.0 (0.8; 4.3)

 

0.3

Obstructive apnea index, events/h

0 (0; 0.2)

0 (0; 0.6)

 

0.6

Mixed apnea index, events/h

0 (0; 0.1)

0.1 (0; 0.1)

 

0.6

Hypopnea index, events/h

0.5 (0; 1.2)

0.8 (0.2; 1.6)

 

0.5

Obstructive apnea hipopnea Index, events/h

0.7 (0.2; 1.3)

0.98 (0.25; 2.75)

 

0.6

Respiratory disturbance index, events/h

1.7 (1.0; 3.2)

2.9 (0.8; 7.0)

 

0.6

Minimal SaO2, %

91 (90; 92)

92 (86; 92)

 

0.5

Average SaO2, %

97 (96; 97)

97 (96; 97)

 

1

Oxygen desaturation index, events/h

1.8 (0.9; 2.9)

2.2 (0.8; 8.1)

 

0.5

  1. a significant difference between FASD patients and the PSG control group
  2. b significant difference between the control group and the PSG control group